ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 70 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,556,040 | -15.7% | 10,969,282 | 0.0% | 0.05% | -16.9% |
Q2 2023 | $10,146,586 | -5.3% | 10,969,282 | +11.6% | 0.06% | +1.7% |
Q1 2023 | $10,715,656 | -25.3% | 9,830,877 | 0.0% | 0.06% | -32.6% |
Q4 2022 | $14,353,080 | +35.8% | 9,830,877 | 0.0% | 0.09% | +24.6% |
Q3 2022 | $10,568,000 | -36.8% | 9,830,877 | 0.0% | 0.07% | -27.4% |
Q2 2022 | $16,712,000 | -17.5% | 9,830,877 | 0.0% | 0.10% | -18.1% |
Q1 2022 | $20,252,000 | -45.1% | 9,830,877 | 0.0% | 0.12% | -35.2% |
Q4 2021 | $36,866,000 | -27.5% | 9,830,877 | 0.0% | 0.18% | -19.7% |
Q3 2021 | $50,826,000 | +21.4% | 9,830,877 | 0.0% | 0.22% | +21.2% |
Q2 2021 | $41,880,000 | -19.8% | 9,830,877 | 0.0% | 0.18% | -18.6% |
Q1 2021 | $52,202,000 | -1.5% | 9,830,877 | 0.0% | 0.23% | +13.0% |
Q4 2020 | $52,988,000 | +4.9% | 9,830,877 | +55.3% | 0.20% | -1.0% |
Q3 2020 | $50,516,000 | -24.4% | 6,330,354 | -5.2% | 0.20% | -31.5% |
Q2 2020 | $66,819,000 | +565.7% | 6,675,181 | +80.9% | 0.30% | +375.8% |
Q1 2020 | $10,038,000 | +745.7% | 3,690,307 | +3590.3% | 0.06% | +588.9% |
Q2 2018 | $1,187,000 | +5.7% | 100,000 | 0.0% | 0.01% | -10.0% |
Q1 2018 | $1,123,000 | +68.1% | 100,000 | 0.0% | 0.01% | +66.7% |
Q4 2017 | $668,000 | -18.4% | 100,000 | 0.0% | 0.01% | -14.3% |
Q3 2017 | $819,000 | +82.4% | 100,000 | 0.0% | 0.01% | +75.0% |
Q2 2017 | $449,000 | -18.5% | 100,000 | 0.0% | 0.00% | -20.0% |
Q1 2017 | $551,000 | +36.0% | 100,000 | 0.0% | 0.01% | +25.0% |
Q4 2016 | $405,000 | -42.6% | 100,000 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $705,000 | -13.5% | 100,000 | 0.0% | 0.01% | -33.3% |
Q2 2016 | $815,000 | +0.2% | 100,000 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $813,000 | -32.6% | 100,000 | 0.0% | 0.01% | -10.0% |
Q4 2015 | $1,206,000 | +0.8% | 100,000 | 0.0% | 0.01% | -9.1% |
Q3 2015 | $1,197,000 | -34.7% | 100,000 | 0.0% | 0.01% | -31.2% |
Q2 2015 | $1,833,000 | – | 100,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |